MacroGenics | MGNX - Ebit


MacroGenics reported $20.16M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Genmab DKK 432M 900.27M Jun/2025
Geron USD -13.89M 1.43M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Xencor USD -47.52M 24.69M Sep/2025